Would electric cars crash the grid?

Widespread adoption of electric cars in New South Wales would increase demand on the power grid by an average of eight per cent, according to new research from the School of Engineering.

Sohaib Rafique and Professor Graham Town used data from the New South Wales Household Travel Survey to determine the demand that electric cars would place on the grid if they were used in 82 per cent of weekday and 81 per cent of weekend commutes, with trips less than 35km in length. Continue reading Would electric cars crash the grid?

Making drug discovery faster, cheaper and safer

A Macquarie University start-up that created a new way to develop drugs faster and more cheaply than current methods, has won a CSIRO innovation award.

Currently it takes over a decade and $2 billion to develop a new drug. Of these, four out of five will never be launched.

If we want everyone in need to have access to affordable and effective medications, we must reduce the time and cost associated with drug development, argues Molecular Sciences’ Professor Peter Karuso.

And that’s what the start-up he founded—Hyperdrive Science—is attempting to do.  Continue reading Making drug discovery faster, cheaper and safer

Are damselflies in distress?

Damselflies are evolving rapidly as they expand their range in response to a warming climate, according to new research led by Macquarie University researchers in Sydney.

“Genes that influence heat tolerance, physiology, and even vision are giving them evolutionary options to help them cope with climate change. Other insects may not be so lucky,” says Dr Rachael Dudaniec, lead author of the paper. Continue reading Are damselflies in distress?

Protecting users’ privacy online

Ten internet searches can be enough to reveal your identity online, according to research from Macquarie University and CSIRO’s Data61 that was presented at The Web Conference 2018 yesterday.

But the researchers have developed a new method—called Incognito—to better protect users’ online privacy through obfuscating the web data they leave behind. Continue reading Protecting users’ privacy online

Transistor model sets the standard

Dr Sourabh Khandelwal from the Department of Engineering has developed a model for a GaN (gallium nitride) transistor that has been adopted as an international standard.

Silicon transistors are a critical part of modern electronics. There’s a few million of them in your smartphone alone, but owing to their fundamental material limitations they’re extremely inefficient for emerging applications.

GaN transistors are emerging as a go-to technology for use in future applications like 5G communications, sensing electronics in autonomous cars, and compact converters for renewable energy. They’re more efficient than silicon, meaning they’ll use less power and can also be made smaller than silicon transistors. Continue reading Transistor model sets the standard

Using nanoparticles to better target cancer tumours

Dr Andrew Care from the Department of Molecular Sciences has been awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.

Andrew’s fellowship will fund research looking at how biological nanoparticles can be used to better deliver anti-cancer drugs to destroy tumours.

Andrew and his team are re-engineering protein-based nanoparticles that are normally found in microorganisms, like bacteria. These re-engineered nanoparticles will be capable of carrying anti-cancer drugs to tumours inside the body. Continue reading Using nanoparticles to better target cancer tumours

Keeping ahead of a child killer: stopping gastro from birth

UPDATE 22 February 2018:  

A vaccine has been developed against rotavirus, which is the common cause  of severe diarrhoea and a killer of approximately 215,000 children under five globally each year.

The oral vaccine was given in three single doses, the first within five days of birth. After three doses of RV3-BB administered from birth:

  • 94 per cent of infants were protected in their first year of life against severe rotavirus gastroenteritis
  • 75 per cent of infants were protected to 18 months of age.

The success of the RV3-BB vaccine is the culmination of more than four decades of work, which started with the Murdoch Children’s Research Institute’s Professor Ruth Bishop and the discovery of rotavirus in 1973.

The trial was funded by the National Health and Medical Research Council (NHMRC), Bill & Melinda Gates Foundation and PT BioFarma.

Read the full media release on the MCRI website.

——

A new rotavirus vaccine should soon be available thanks to a collaboration between PT Bio Farma and researchers in Melbourne and Yogyakarta. The new ‘RV3’ vaccine is aimed at protecting babies from birth, improving protection and simplifying delivery.

The current vaccine, available in Australia and only on the private market in Indonesia, can only be administered from six weeks of age.

Continue reading Keeping ahead of a child killer: stopping gastro from birth

Fresh Science

Fresh Science helps Australian early-career researchers find their story and their voice.

Over the past 20 years Fresh Science has trained and empowered more than 500 future leaders in science to engage with the community, media, government and industry.

In 2016, we chose 60 researchers around the country, trained them, and gave them the chance to present their science in pubs, school talks and to the media. Here are a few of their stories.

Continue reading Fresh Science